CYP2C19 Ultrarapid Phenotype as a Risk Predictor of Subsequent Events During Clopidogrel Treatment in Patients Undergoing a Percutaneous Neurointervention

  1. Saiz-Rodríguez, M.
  2. Belmonte, C.
  3. Abad-Santos, F.
Zeitschrift:
Clinical Pharmacology and Therapeutics

ISSN: 1532-6535,  0009-9236

Datum der Publikation: 2019

Ausgabe: 105

Nummer: 5

Seiten: 1074-1075

Art: Brief

DOI: 10.1002/CPT.1300 GOOGLE SCHOLAR
Datenquelle: Scopus